Aquestive Therapeutics, Inc. (AQST)
5.395
+0.04
(+0.84%)
USD |
NASDAQ |
Sep 04, 11:31
Aquestive Therapeutics Research and Development Expense (TTM) : 15.89M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.89M |
| March 31, 2026 | 16.04M |
| December 31, 2025 | 17.19M |
| September 30, 2025 | 18.91M |
| June 30, 2025 | 19.65M |
| March 31, 2025 | 19.71M |
| December 31, 2024 | 20.28M |
| September 30, 2024 | 18.25M |
| June 30, 2024 | 16.18M |
| March 31, 2024 | 15.49M |
| December 31, 2023 | 13.10M |
| September 30, 2023 | 14.46M |
| June 30, 2023 | 14.49M |
| March 31, 2023 | 16.22M |
| December 31, 2022 | 17.44M |
| September 30, 2022 | 17.60M |
| June 30, 2022 | 19.10M |
| March 31, 2022 | 18.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.05M |
| September 30, 2021 | 17.07M |
| June 30, 2021 | 19.61M |
| March 31, 2021 | 19.19M |
| December 31, 2020 | 19.89M |
| September 30, 2020 | 18.52M |
| June 30, 2020 | 16.32M |
| March 31, 2020 | 20.62M |
| December 31, 2019 | 20.57M |
| September 30, 2019 | 23.20M |
| June 30, 2019 | 22.67M |
| March 31, 2019 | 22.51M |
| December 31, 2018 | 23.11M |
| September 30, 2018 | 23.70M |
| June 30, 2018 | 24.85M |
| March 31, 2018 | 21.69M |
| December 31, 2017 | 22.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 3.791M |
| ANI Pharmaceuticals, Inc. | 49.91M |
| Corcept Therapeutics, Inc. | 253.86M |
| Veru, Inc. | 11.76M |
| Johnson & Johnson | 15.06B |